Search Within

Daniel Tylawsky

Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  3. GSK Faculty (7)
  4. MSK Grad Students (7)
  5. Molecular Pharmacology and Chemistry Program Faculty (7)
  6. Sloan Kettering Institute Faculty (7)

More Groups

People
  1. Daniel Heller (7)
  2. Janki Shah (4)
  3. Hiroto Kiguchi (3)
  4. Praveen Raju (2)
  5. Yosef Shamay (2)
  6. Ana Perea Del Angel (1)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (1)
  5. 2020 (1)
  6. 2019 (1)
Publications
  1. Neuro-Oncology (4)
  2. ACS Chemical Biology (1)
  3. Journal of Neuropathology and Experimental Neurology (1)
  4. Nature Materials (1)
Publishers
  1. Oxford University Press (5)
  2. American Chemical Society (1)
  3. Nature Publishing Group (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phospholipase PAFAH2 mediates ferroptosis surveillance and lipid remodeling to promote resistance in KEAP1 mutant cancers
    Journal Article

    Ruiz, S. B.; Tylawsky, D. E.; Shah, J.; Saoi, M.; Cuevas, B.; Desai, S.; Racz, B.; Perea, A. M.; Izawa-Ishiguro, A. R.; Cross, J.; more...
    ACS Chemical Biology (2025)

    Fulltext@MSK | Save
  • Enhancement of blood-brain barrier penetration and tumor targeted drug delivery for DMG using a P-selectin targeted nanomedicine approach
    Meeting Abstract

    Li, B. K.; Vaynshteyn, J.; Tylawsky, D.; Vogt, K.; Raziuddin, R.; Ge, Y.; Heller, D. A.; Becher, O.; Raju, G. P.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Inducing neural maturation in medulloblastoma by targeting EZH2
    Meeting Abstract

    Snuderl, M.; Galbraith, K.; Tylawsky, D.; Liechty, B.; Vaynshteyn, J.; Gerwin, J.; Orillac, C.; Boué, D.; Heller, D.; Raju, G.
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis
    Journal Article

    Tylawsky, D. E.; Kiguchi, H.; Vaynshteyn, J.; Gerwin, J.; Shah, J.; Islam, T.; Boyer, J. A.; Boué, D. R.; Snuderl, M.; Greenblatt, M. B.; more...
    Nature Materials (2023)

    Fulltext@MSK | Save
  • A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
    Meeting Abstract

    Raju, P.; Tylawsky, D.; Vaynshteyn, J.; Gerwin, J.; Heller, D.; Snuderl, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Nanotherapeutic targeting of tumor endothelium for enhancing drug delivery past the blood-brain barrier
    Meeting Abstract

    Kiguchi, H.; Tylawsky, D.; Vaynshteyn, J.; Gerwin, J.; Manzari, M.; Shah, J.; Li, N.; Shamay, Y.; Greenblatt, M.; Heller, D.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Nanotherapeutic targeting of tumor endothelium for enhancing drug delivery past the blood-brain barrier
    Meeting Abstract

    Kiguchi, H.; Manzari, M.; Vaynshteyn, J.; Gerwin, J.; Tylawsky, D.; Li, N.; Shah, J.; Shamay, Y.; Greenblatt, M.; Heller, D.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save